Novel Hyperbranched Rolling Circle Amplification-Driven Aptasensor for Ultrasensitive and Multiplex Biomarkers Detection of Alzheimer's Disease

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Sensors and Actuators B: Chemical

• Publication date

  2025-04-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.snb.2025.137816
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor Cell-Specific Signal Processing Platform Controlled by ATP for Non-invasive Modulation of Cellular Behavior.

  2024cited by this paper
• The global macroeconomic burden of Alzheimer's disease and other dementias: estimates and projections for 152 countries or territories.

  2024cited by this paper
• Gold Nanoparticle-Decorated Catalytic Micromotor-Based Aptassay for Rapid Electrochemical Label-Free Amyloid-β42 Oligomer Determination in Clinical Samples from Alzheimer’s Patients

  2024cited by this paper
• Self-calibrating surface-enhanced Raman scattering-lateral flow immunoassay for determination of amyloid-β biomarker of Alzheimer's disease.

  2023cited by this paper
• Advances in targeted tracking and detection of soluble amyloid-β aggregates as a biomarker of Alzheimer's disease.

  2023cited by this paper
• Improving aptamer performance: key factors and strategies

  2023cited by this paper
• Functional Nanomaterials for the Diagnosis of Alzheimer’s Disease: Recent Progress and Future Perspectives

  2023cited by this paper
• A label-free dually-amplified aptamer sensor for the specific detection of amyloid-beta peptide oligomers in cerebrospinal fluids.

  2023cited by this paper
• Dumbbell Aptamer Sensor Based on Dual Biomarkers for Early Detection of Alzheimer's Disease.

  2023cited by this paper
• A colorimetric and photothermal dual-mode biosensing platform based on nanozyme-functionalized flower-like DNA structures for tumor-derived exosome detection.

  2023cited by this paper
• Recent applications of rolling circle amplification in biosensors and DNA nanotechnology

  2023cited by this paper
• CRISPR-Powered Aptasensor for Diagnostics of Alzheimer's Disease.

  2023cited by this paper
• A Universal Strategy for Enhancing the Circulating miRNAs’ Detection Performance of Rolling Circle Amplification by Using a Dual-Terminal Stem-Loop Padlock

  2023cited by this paper
• Global and regional projections of the economic burden of Alzheimer's disease and related dementias from 2019 to 2050: A value of statistical life approach

  2022cited by this paper
• Recent Advances in Aptamer-Based Biosensors for Global Health Applications.

  2021cited by this paper
• Quantitative assessment of AD markers using naked eyes: point-of-care testing with paper-based lateral flow immunoassay

  2021cited by this paper
• Construction and bioapplications of aptamer-based dual recognition strategy.

  2021cited by this paper
• Ultrasensitive assay of amyloid-beta oligomers using Au-vertical graphene/carbon cloth electrode based on poly(thymine)-templated copper nanoparticles as probes

  2021cited by this paper
• Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (IWG)

  2021cited by this paper
• Rolling Circle Replication for Biosensing, Bioimaging, and Biomedicine.

  2021cited by this paper
• Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications.

  2020cited by this paper
• Gold nanoparticles assisted sensitivity improvement of interdigitated microelectrodes biosensor for amyloid-β detection in plasma sample

  2020cited by this paper
• Dementia prevention, intervention, and care: 2020 report of the Lancet Commission

  2020cited by this paper
• Development of DNA Aptamer as a β-Amyloid Aggregation Inhibitor.

  2020cited by this paper
• Integrating CuO/g-C3N4 p-n heterojunctioned photocathode with MoS2 QDs@Cu NWs multifunctional signal amplifier for ultrasensitive detection of AβO.

  2020cited by this paper
• Alzheimer Disease: An Update on Pathobiology and Treatment Strategies

  2019cited by this paper
• Robust and Universal SERS Sensing Platform for Multiplexed Detection of Alzheimer's Disease Core Biomarkers Using PAapt-AuNPs Conjugates.

  2019cited by this paper
• Amperometric Aptasensor for Amyloid-beta Oligomer Detection by Optimized Stem-loop Structures with Adjustable Detection Range.

  2019cited by this paper
• Amyloid-β-independent regulators of tau pathology in Alzheimer disease

  2019cited by this paper
• Simultaneous Monitoring of Amyloid-β (Aβ) Oligomers and Fibrils for Effectively Evaluating the Dynamic Process of Aβ Aggregation.

  2019cited by this paper
• Monitoring amyloid-β proteins aggregation based on label-free aptasensor

  2019cited by this paper
• Longitudinal tau PET in ageing and Alzheimer’s disease

  2018cited by this paper
• Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade.

  2018cited by this paper
• Ligation-promoted hyperbranched rolling circle amplification enables ultrasensitive detection of microRNA in clinical specimens

  2018cited by this paper
• Alzheimer's disease: The right drug, the right time

  2018cited by this paper
• Amyloid-β and tau complexity — towards improved biomarkers and targeted therapies

  2018cited by this paper
• A test of AMBER force fields in predicting the secondary structure of α-helical and β-hairpin peptides

  2017cited by this paper
• Aptamer-based detection of adenosine triphosphate via qPCR.

  2017cited by this paper
• Highly Selective and Sensitive Electrochemiluminescence Biosensor for p53 DNA Sequence Based on Nicking Endonuclease Assisted Target Recycling and Hyperbranched Rolling Circle Amplification.

  2016cited by this paper
• Droplet-based magnetic bead immunoassay using microchannel-connected multiwell plates (μCHAMPs) for the detection of amyloid beta oligomers.

  2016cited by this paper
• CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.

  2016cited by this paper
• Clinical utility and analytical challenges in measurement of cerebrospinal fluid amyloid-β(1-42) and τ proteins as Alzheimer disease biomarkers.

  2013cited by this paper
• Sensitive and label-free DNA methylation detection by ligation-mediated hyperbranched rolling circle amplification.

  2012cited by this paper
• Alzheimer mechanisms and therapeutic strategies.

  2012cited by this paper
• Selection of DNA aptamers that recognize α-synuclein oligomers using a competitive screening method.

  2012cited by this paper
• Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play.

  2012cited by this paper
• Structural conversion of neurotoxic amyloid-β(1–42) oligomers to fibrils

  2010cited by this paper
• Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease

  2010cited by this paper

• Recent Advances in Micro- and Nano-Enhanced Intravascular Biosensors for Real-Time Monitoring, Early Disease Diagnosis, and Drug Therapy Monitoring

  2025cites this paper
• The peptide functionalized Electrochemiluminescence biosensor based on aptamer toehold-mediated Strand displacement reaction for ultrasensitive detection of Aβ-42

  2025cites this paper